Alzheimer's Disease Center
The Alzheimer's Disease Center at UT Southwestern is dedicated to finding ways to treat and prevent this devastating illness, which is predicted to rise to 12 million cases by 2030. Through this website, we hope to educate people with Alzheimer's and their loved ones about the research, treatment, and support available here.
Latest News
22nd Annual Myron F. Weiner Geriatric Psychiatry Update
Saturday, February 4, 2012
The program presents an overview of the latest clinical and research findings in the field of Geriatric Psychiatry, with focus on evaluation of functional abilities in cognitive disorders, effects of amyloid pathology on cognitive function, and ethical issues in advanced Alzheimer's Disease. Practical information on management and diagnosis of delirium and advances in the understanding and treatment of Alzheimer’s disease will be presented via didactic lectures, slides and handouts. Health care professionals and the general public are invited.
Register online.
Translational Research in Mechanisms of Neurodegeneration
Friday, February 10, 2012 8am-4pm
The Alzheimer's Disease Center at UT Southwestern presents a symposium for medical students, residents, fellows, doctoral students, postdocs, MDs, PhDs, researchers. UT Southwestern is moving rapidly toward becoming a leader in unraveling the mechanisms of neurodegenerative disease and working toward treatment of these diseases. This is an opportunity to learn about your colleagues’ ground-breaking research, to interact with them, to develop and explore your own ideas and to learn about funding opportunities here at UT Southwestern. You will also learn about the patient-related resources available through our federally- funded UT Southwestern Alzheimer’s Disease Center.
Alzheimer's Disease Center awarded $5 million grant
The National Institute on Aging of the National Institutes of Health has renewed the Alzheimer’s Disease Center (ADC) grant for another five years. The NIH grant award is for $9 million and is the fifth consecutive grant renewal for the ADC dating back to 1988. “We look forward to a highly productive and exciting five years ahead of renewed funding for our research,” said Roger N. Rosenberg, M.D, Director of the ADC.
Early-Stage Efforts to Discover Drugs That Preserve Brain Cells
The Friends of the Alzheimer’s Disease Center hosted a public forum on Wednesday, March 23, to hear Steven McKnight, PhD, Chair of the Department of Biochemistry. Dr. McKnight and his colleagues have discovered, in a laboratory setting, a small molecule that can boost learning and memory as well as prevent new brain cells from dying. They are working to “polish” this early-stage drug lead so that it might help patients suffering from various neurodegenerative diseases, such as Alzheimer’s disease. Andrew Pieper, MD, PhD, one of Dr. McKnight’s co-investigators, partners with him in the presentation. Watch a video of Drs. McKnight and Pieper discussing early-stage efforts to discover drugs that preserve brain cells.